Metabolic dysfunction, as seen in obesity and diabetes, amplifies oxidative burden through NADPH oxidase activation, lipid peroxidation, and impaired glutathione recycling, further aggravating post-ischemic inflammation. This evidence concerns the gene FMO5 and obesity due to melanocortin 4 receptor deficiency.